Back
Atossa Therapeutics Stock Predictions
Buy
78
ATOS
Atossa Therapeutics
Last Price:
1.57
Seasonality Move:
9.77%
7 Day Trial
ALL ACCESS PASS
$
7
Atossa Therapeutics Stock Forecast
-
Is Atossa Therapeutics Stock Undervalued?
The current Atossa Therapeutics [ATOS] share price is $1.57. The Score for ATOS is 78, which is 56% above its historic median score of 50, and infers lower risk than normal. - ATOS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Atossa Therapeutics Stock Go Up Next Year?
Data Unavailable
Atossa Therapeutics Stock Rating
Data Unavailable
Atossa Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
atossatherapeutics.com
52-Week Data
52-Week High:
2.31
52-Week Low:
0.62
Prediction Charts
Market Cap:
197.44M
Price in USD:
1.57
Volume:
806.93K
Beta:
1.01
Technical Analysis
SMA50:
1.59
SMA100:
1.26
SMA200:
1.02
52-Wk Change:
121.13%
Stock Predictions
-
Is Atossa Therapeutics stock public?
Yes, Atossa Therapeutics is a publicly traded company. -
What is the Atossa Therapeutics stock quote today?
The Atossa Therapeutics stock price is 1.57 USD today. -
How to buy Atossa Therapeutics stock online?
You can buy Atossa Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-30 | 1.53 | 1.51 | 1.59 | 1.47 |
| May-1 | 1.51 | 1.53 | 1.54 | 1.47 |
| May-2 | 1.54 | 1.52 | 1.57 | 1.49 |
| May-3 | 1.53 | 1.66 | 1.70 | 1.53 |
| May-6 | 1.69 | 1.73 | 1.78 | 1.67 |
| May-7 | 1.71 | 1.71 | 1.78 | 1.67 |
| May-8 | 1.71 | 1.68 | 1.81 | 1.67 |
| May-9 | 1.71 | 1.69 | 1.74 | 1.61 |
| May-10 | 1.69 | 1.49 | 1.72 | 1.48 |
| May-13 | 1.45 | 1.47 | 1.52 | 1.42 |
| May-14 | 1.43 | 1.54 | 1.59 | 1.41 |
| May-15 | 1.58 | 1.61 | 1.69 | 1.57 |
| May-16 | 1.62 | 1.61 | 1.66 | 1.55 |
| May-17 | 1.60 | 1.57 | 1.60 | 1.55 |
Atossa Therapeutics Earnings
Data Unavailable
Atossa Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.05 per share.
* Atossa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.